Anaesthesia
-
“Inhalational anaesthetic agents are chlorofluorocarbons, ‘greenhouse gases’ that have between 349 (sevoflurane) and 3714 (desflurane) times the global warming potential over a 20 year time horizon of carbon dioxide (isoflurane 1401), equivalent to driving a car 18 (sevoflurane) to ~350 miles (desflurane) per hour of anaesthetic use (isoflurane 30 miles); these figures do not account for the additional carbon cost of heating desflurane vaporisers. Together with nitrous oxide, inhalational anaesthetic agents contribute ~2.5% of the 22.8 million tonnes of carbon dioxide equivalents the NHS produces annually.” - White
summary -
Multicenter Study
The effect of fresh gas flow during induction of anaesthesia on sevoflurane usage: a quality improvement study.
Modest reductions in fresh gas flow at the beginning of anaesthesia induction results in meaningful reduction in sevoflurane consumption.
pearl -
Multicenter Study
Protocolised thromboelastometric-guided haemostatic management in patients with traumatic brain injury: a pilot study.
Coagulopathy in patients with traumatic brain injury is associated with an increase in morbidity and mortality. Although timely and aggressive treatment of coagulopathy is of paramount importance, excessive transfusion of blood products has been linked with poor long-term outcomes in patients with traumatic brain injury. A point-of-care thromboelastometric-guided algorithm could assist in creating a more individually tailored approach to each patient. ⋯ Although only 5 out of 32 patients had abnormalities of conventional coagulation tests, 21 out of 32 patients had a coagulopathic baseline thromboelastometric trace. Implementing a thromboelastometric-guided algorithm for the haemostatic therapy of traumatic brain injury is feasible in centres formerly naïve to this technology and may lead to more rapid and precise coagulation management. Further large-scale studies are warranted to confirm the results of this pilot trial and evaluate clinical outcomes.
-
Central venous catheter insertion is a routine procedure performed by anaesthetists in the peri-operative setting. Upper body central venous catheters are usually placed such that their tip lies within the superior vena cava or at the cavo-atrial junction. Positioning the tip 'too low' in the right atrium has long been argued against on the basis that it increases the risk of perforation, leading to cardiac tamponade. ⋯ We conducted a three-month pre-intervention audit (n = 84) in 2016 and a post-intervention audit (n = 84) in 2017. Compared with the pre-intervention audit, the post-intervention audit coincided with a lower rate of central venous catheter tip malpositioning (5.6% vs. 9.2%); and a higher rate of 'optimal' central venous catheter tip position in the distal superior vena cava or cavo-atrial junction (45.1% vs. 29.2%). The central venous catheter insertion checklist also substantially improved documentation of sterility measures, insertion depth and post-insertional documentation of tip position on chest radiograph.